Delivery Order SPE2DB22D9353-SPE2DB25FX1WL
Award Date
5/13/25
Potential Completion Date
6/4/25
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $66,359.82 contract is for the delivery of the medication UPTRAVI 800 MCG tablets. The delivery order has a completion date of March 28, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA, valued at up to $4,999,999, to provide a range of...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,548.06 contract is for the delivery of UPTRAVI 1,600 MCG tablets to support the recurring medical supply needs of military healthcare facilities. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $75,307.08 firm fixed-price delivery order is for the supply of UPTRAVI 600 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery...
This federal contract award, valued at $75,379.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of UPTRAVI 800 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This contract award is for the delivery of UPTRAVI 800 MCG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $69,320.52, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, running through September 24, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the...
The federal contract award, with ID SPE2DB22D9353|SPE2DB25FX1LM, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,644.18 firm fixed-price delivery order is for the supply of 4566595907 - UPTRAVI 1,600 MCG TABLET 60S, with a period of performance through November 27, 2024. This award is under a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $75,556.44 contract is for the provision of 60 tablets of the pharmaceutical product UPTRAVI 800 MCG. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC, which is valid through November 2026,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of Uptravi 1,600 MCG tablets. The $11,548.06 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense. The contract has an ultimate completion date of November 26, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain,...
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at sixty-six thousand three hundred fifty-nine dollars and eighty-two cents ($66,359.82) by the Defense Logistics Agency Troop Support Medical to provide 800 microgram UpTravi tablets, 60 count. The delivery order was issued against an existing indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency, with a potential value of up to five million dollars, to supply...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,868.68, is for the delivery of 4564813182 TRUQAP 200 MG TABLET 64S, a pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...